RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...
The Economic Hardship Reporting Project and The Chronicle of Philanthropy report on Dexter Hall's advocacy for hiring staff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback